Literature DB >> 25339735

Regulation of presynaptic Ca2+, synaptic plasticity and contextual fear conditioning by a N-terminal β-amyloid fragment.

James L M Lawrence1, Mei Tong2, Naghum Alfulaij1, Tessi Sherrin1, Mark Contarino3, Michael M White3, Frederick P Bellinger1, Cedomir Todorovic1, Robert A Nichols4.   

Abstract

Soluble β-amyloid has been shown to regulate presynaptic Ca(2+) and synaptic plasticity. In particular, picomolar β-amyloid was found to have an agonist-like action on presynaptic nicotinic receptors and to augment long-term potentiation (LTP) in a manner dependent upon nicotinic receptors. Here, we report that a functional N-terminal domain exists within β-amyloid for its agonist-like activity. This sequence corresponds to a N-terminal fragment generated by the combined action of α- and β-secretases, and resident carboxypeptidase. The N-terminal β-amyloid fragment is present in the brains and CSF of healthy adults as well as in Alzheimer's patients. Unlike full-length β-amyloid, the N-terminal β-amyloid fragment is monomeric and nontoxic. In Ca(2+) imaging studies using a model reconstituted rodent neuroblastoma cell line and isolated mouse nerve terminals, the N-terminal β-amyloid fragment proved to be highly potent and more effective than full-length β-amyloid in its agonist-like action on nicotinic receptors. In addition, the N-terminal β-amyloid fragment augmented theta burst-induced post-tetanic potentiation and LTP in mouse hippocampal slices. The N-terminal fragment also rescued LTP inhibited by elevated levels of full-length β-amyloid. Contextual fear conditioning was also strongly augmented following bilateral injection of N-terminal β-amyloid fragment into the dorsal hippocampi of intact mice. The fragment-induced augmentation of fear conditioning was attenuated by coadministration of nicotinic antagonist. The activity of the N-terminal β-amyloid fragment appears to reside largely in a sequence surrounding a putative metal binding site, YEVHHQ. These findings suggest that the N-terminal β-amyloid fragment may serve as a potent and effective endogenous neuromodulator.
Copyright © 2014 the authors 0270-6474/14/3414210-09$15.00/0.

Entities:  

Keywords:  Ca regulation; fear memory; neuromodulation; synaptic plasticity; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 25339735      PMCID: PMC4205547          DOI: 10.1523/JNEUROSCI.0326-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  Alpha v integrins mediate beta-amyloid induced inhibition of long-term potentiation.

Authors:  Qinwen Wang; Igor Klyubin; Sarah Wright; Irene Griswold-Prenner; Michael J Rowan; Roger Anwyl
Journal:  Neurobiol Aging       Date:  2007-04-17       Impact factor: 4.673

2.  Long-lasting synaptic modification in the rat hippocampus resulting from NMDA receptor blockade during development.

Authors:  Frederick P Bellinger; Peter A Wilce; Kuldip S Bedi; Peter Wilson
Journal:  Synapse       Date:  2002-02       Impact factor: 2.562

3.  A novel pathway for amyloid precursor protein processing.

Authors:  Erik Portelius; Eric Price; Gunnar Brinkmalm; Mark Stiteler; Maria Olsson; Rita Persson; Ann Westman-Brinkmalm; Henrik Zetterberg; Adam J Simon; Kaj Blennow
Journal:  Neurobiol Aging       Date:  2009-07-14       Impact factor: 4.673

4.  beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

Authors:  D L Pettit; Z Shao; J L Yakel
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 5.  Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.

Authors:  Aarti N Patel; Jack H Jhamandas
Journal:  Expert Rev Mol Med       Date:  2012-01-20       Impact factor: 5.600

6.  Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network.

Authors:  D M Skovronsky; D B Moore; M E Milla; R W Doms; V M Lee
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

Review 7.  Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

Authors:  T E Golde; C B Eckman; S G Younkin
Journal:  Biochim Biophys Acta       Date:  2000-07-26

8.  Synapse formation between clonal neuroblastoma X glioma hybrid cells and striated muscle cells.

Authors:  P Nelson; C Christian; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

9.  Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.

Authors:  Cosma D Dellisanti; Yun Yao; James C Stroud; Zuo-Zhong Wang; Lin Chen
Journal:  Nat Neurosci       Date:  2007-07-22       Impact factor: 24.884

Review 10.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

View more
  22 in total

Review 1.  The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.

Authors:  D Puzzo; W Gulisano; O Arancio; A Palmeri
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

2.  Medical school hotline: the research mission of the cell and molecular biology department and program at the john a. Burns school of medicine.

Authors:  Marla J Berry; Joshua Astern; Frederick Bellinger; Christopher Brampton; Rebecca Cann; Mariana Gerschenson; David Haymer; Nicholas G James; David M Jameson; Olivier LeSaux; Peter R Hoffmann; Robert Nichols; Matthew Pitts; Lucia Seale; Steven Seifried; Alexander J Stokes; Cedomir Todorovic
Journal:  Hawaii J Med Public Health       Date:  2015-04

3.  Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.

Authors:  Agostino Palmeri; Roberta Ricciarelli; Walter Gulisano; Daniela Rivera; Claudia Rebosio; Elisa Calcagno; Maria Rosaria Tropea; Silvia Conti; Utpal Das; Subhojit Roy; Maria Adelaide Pronzato; Ottavio Arancio; Ernesto Fedele; Daniela Puzzo
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

4.  Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory.

Authors:  Walter Gulisano; Marcello Melone; Cristian Ripoli; Maria Rosaria Tropea; Domenica D Li Puma; Salvatore Giunta; Sara Cocco; Daniele Marcotulli; Nicola Origlia; Agostino Palmeri; Ottavio Arancio; Fiorenzo Conti; Claudio Grassi; Daniela Puzzo
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

5.  Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition.

Authors:  Max C Richter; Susann Ludewig; Alex Winschel; Tobias Abel; Charlotte Bold; Leonie R Salzburger; Susanne Klein; Kang Han; Sascha W Weyer; Ann-Kristina Fritz; Bodo Laube; David P Wolfer; Christian J Buchholz; Martin Korte; Ulrike C Müller
Journal:  EMBO J       Date:  2018-04-16       Impact factor: 11.598

Review 6.  Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Santiago Rivera; Laura García-González; Michel Khrestchatisky; Kévin Baranger
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

Review 7.  Not just amyloid: physiological functions of the amyloid precursor protein family.

Authors:  Ulrike C Müller; Thomas Deller; Martin Korte
Journal:  Nat Rev Neurosci       Date:  2017-03-31       Impact factor: 34.870

Review 8.  The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.

Authors:  Min Xia; Xiaofang Cheng; Ruofan Yi; Dong Gao; Jiaxiang Xiong
Journal:  Mol Neurobiol       Date:  2014-12-04       Impact factor: 5.590

9.  JIP1-Mediated JNK Activation Negatively Regulates Synaptic Plasticity and Spatial Memory.

Authors:  Caroline Morel; Tessi Sherrin; Norman J Kennedy; Kelly H Forest; Seda Avcioglu Barutcu; Michael Robles; Ezekiel Carpenter-Hyland; Naghum Alfulaij; Claire L Standen; Robert A Nichols; Morris Benveniste; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

Review 10.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.